Nasal drug delivery -: evaluation of an in vitro model using porcine nasal mucosa

被引:56
|
作者
Wadell, C [1 ]
Björk, E
Camber, O
机构
[1] Pharmacia & Upjohn Inc, Stockholm, Sweden
[2] Univ Uppsala, Dept Pharmaceut, S-75105 Uppsala, Sweden
[3] Astra Arcus AB, Sodertalje, Sweden
关键词
nasal mucosa; pig; ussing chamber; electrophysiology; permeability; viability;
D O I
10.1016/S0928-0987(98)00023-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An in vitro model for permeation studies using porcine nasal mucosa was developed and evaluated. The viability and integrity of the mucosa were determined by electrophysiological measurements, permeation studies involving C-14-mannitol and D-(2-H-3) glucose, histological studies and a biochemical assay. Enzymatic activity in the mucosa was determined by serosal addition of ouabain. Three different types of porcine nasal mucosa (cavity mucose, natural septum mucosa and dermatomed septum mucosa) were examined. The results showed that cavity mucosa was the most suitable; this type remained viable for up to 8 h after removal. Lower limits for electrophysiological data were defined in order to establish criteria for tissue viability. This in vitro method using porcine nasal mucosa appears potentially valuable as a tool for further permeation and mechanistic studies within nasal drug delivery research. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 50 条
  • [1] Porcine nasal mucosa as a suitable model for intranasal drug delivery
    Ladel, S.
    Flamm, J.
    Rosmer, S.
    Walter, J. C.
    Filtzwieser, D.
    Schlossbauer, P.
    Deing, P.
    Schindowski, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S80 - S80
  • [2] Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts
    Djupesland, Per G.
    Messina, John C.
    Mahmoud, Ramy A.
    THERAPEUTIC DELIVERY, 2020, 11 (08) : 485 - 495
  • [3] Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model
    Gholizadeh, Hanieh
    Ong, Hui Xin
    Bradbury, Peta
    Kourmatzis, Agisilaos
    Traini, Daniela
    Young, Paul
    Li, Ming
    Cheng, Shaokoon
    EXPERT OPINION ON DRUG DELIVERY, 2021, 18 (06) : 803 - 818
  • [4] IN VITRO EVALUATION OF PEDIATRIC NASAL AND PARANASAL DRUG DELIVERY
    Golshahi, Laleh
    Hosseini, Sana
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (03) : A27 - A27
  • [5] In vitro evaluation of thiomer microparticles for nasal drug delivery
    Greimel, A.
    Del Curto, M. Dorly
    D'Antonio, M.
    Palmberger, T.
    Sprinzl, G. M.
    Bernkop-Schnurch, A.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2006, 16 (02) : 103 - 108
  • [6] In vitro evaluation of regional nasal drug delivery using multiple anatomical nasal replicas of adult human subjects and two nasal sprays
    Manniello, Michele Dario
    Hosseini, Sana
    Alfaifi, Ali
    Esmaeili, Amir R.
    Kolanjiyil, Arun, V
    Walenga, Ross
    Babiskin, Andrew
    Sandell, Dennis
    Mohammadi, Reza
    Schuman, Theodore
    Hindle, Michael
    Golshahi, Laleh
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 593
  • [7] The Path from Nasal Tissue to Nasal Mucosa on Chip: Part 1-Establishing a Nasal In Vitro Model for Drug Delivery Testing Based on a Novel Cell Line
    Bendas, Sebastian
    Koch, Eugen Viktor
    Nehlsen, Kristina
    May, Tobias
    Dietzel, Andreas
    Reichl, Stephan
    PHARMACEUTICS, 2023, 15 (09)
  • [8] Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium
    Schmidt, MC
    Simmen, D
    Hilbe, M
    Boderke, P
    Ditzinger, G
    Sandow, J
    Lang, S
    Rubas, W
    Merkle, HP
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 89 (03) : 396 - 407
  • [9] In Vitro Anatomical Models for Nasal Drug Delivery
    Williams, Gerallt
    Suman, Julie D.
    PHARMACEUTICS, 2022, 14 (07)
  • [10] Permeability of porcine nasal mucosa correlated with human nasal absorption
    Wadell, C
    Björk, E
    Camber, O
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (01) : 47 - 53